Fluticasone propionate side effects in children
Pro Research Analysisby 
Searched over 200M research papers
Fluticasone Propionate Side Effects in Children: Asthma Treatment Safety
Common and Dose-Dependent Side Effects of Fluticasone Propionate in Children
Fluticasone propionate is widely used to manage asthma in children, but its side effects depend strongly on the dose. At high doses (500–1,000 μg/day), children may experience significant reductions in growth velocity, bone turnover, and adrenal cortical function. These effects are much less likely at conventional or recommended doses (≤200 μg/day), which appear to be safe for long-term use in childhood asthma management 19. Reports of growth retardation and adrenal suppression have been documented in children receiving high doses, especially when used as an alternative to oral corticosteroids for severe asthma 279.
Short-Term Safety and Mild Side Effects
Short-term studies (up to 12 weeks) using moderate doses (125–500 μg/day) in children with asthma have shown that fluticasone propionate is generally well tolerated, with no significant side effects such as oral candidiasis, hoarseness, or bronchospasm reported during the study period . Similarly, in infants and young children, inhaled fluticasone propionate administered via spacer and face mask did not result in significant side effects, supporting its safety in this age group .
Long-Term Safety: Ocular and Systemic Effects
Long-term use of inhaled fluticasone propionate at recommended doses (average 320 μg/day) for 3–6 years in children did not show any adverse effects on eye health, including cataract formation, ocular hypertension, or dry eye. No correlation was found between total steroid dosage and ocular side effects, suggesting that long-term, intermittent treatment is safe for ocular functions in children .
Topical Fluticasone Propionate in Pediatric Dermatoses
When used as a topical cream (0.05%) for pediatric skin conditions, fluticasone propionate has shown a good safety profile. Studies in children as young as 3 months and up to 12 years old, treated for 3–6 weeks, found no significant systemic or cutaneous side effects, with only rare cases of mild skin hypopigmentation 48. Serum cortisol levels remained stable, and no significant adrenal suppression was observed .
Adverse Effects in High-Dose and Special Cases
Serious systemic side effects, such as symptomatic adrenal insufficiency and hypoglycemia, have been reported in children receiving high-dose inhaled fluticasone propionate. These cases highlight the risk of adrenal suppression and growth retardation at doses much higher than recommended, especially in children with severe asthma 79. The high lipophilicity and tissue distribution of fluticasone may contribute to these effects at elevated doses .
Immune Function and General Tolerability
Fluticasone propionate, when used as part of combination therapy for asthma, has not been associated with an increased risk of common adverse reactions such as nausea, vomiting, rash, or dizziness. Its use may also improve immune function markers in children with asthma, without increasing the risk of side effects .
Conclusion
Fluticasone propionate is generally safe and effective for treating asthma and skin conditions in children when used at recommended doses and for appropriate durations. The risk of significant side effects, such as growth suppression and adrenal insufficiency, increases with higher doses and prolonged use. Careful monitoring and adherence to recommended dosing guidelines are essential to minimize risks, especially in children requiring long-term or high-dose therapy 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic